11.7. Analysis.
Comparison 11 Triphasic GTD 50‐70‐100 μg and EE 30‐40‐30 μg versus monophasic DSG 150 μg and EE 30 μg, Outcome 7 Proportion of women with breakthrough bleeding at cycle 3.
Comparison 11 Triphasic GTD 50‐70‐100 μg and EE 30‐40‐30 μg versus monophasic DSG 150 μg and EE 30 μg, Outcome 7 Proportion of women with breakthrough bleeding at cycle 3.